JCB logo
Avanti Polar Lipids, Inc.
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents
Published online
doi:10.1083/jcb.200705002
The Journal of Cell Biology, Vol. 179, No. 4, 761-775
The Rockefeller University Press, 0021-9525 $30.00
© Furman et al.
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 4916K)
Right arrow PPT slides of all figures
Right arrow Supplemental Material Index
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Furman, C.
Right arrow Articles by Gertler, F. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Furman, C.
Right arrow Articles by Gertler, F. B.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Article

Ena/VASP is required for endothelial barrier function in vivo



Craig Furman1, Alisha L. Sieminski2, Adam V. Kwiatkowski1, Douglas A. Rubinson1, Eliza Vasile1, Roderick T. Bronson3, Reinhard Fässler4, and Frank B. Gertler1

1 Center for Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139
2 Department of Bioengineering, Franklin W. Olin College of Engineering, Needham, MA 02492
3 Department of Pathology, Harvard Medical School, Boston, MA 02115
4 Department for Molecular Medicine, Max Planck Institute for Biochemistry, D-82157 Martinsried, Germany

Correspondence to Frank B. Gertler: fgertler{at}mit.edu

Enabled/vasodilator-stimulated phosphoprotein (Ena/VASP) proteins are key actin regulators that localize at regions of dynamic actin remodeling, including cellular protrusions and cell–cell and cell–matrix junctions. Several studies have suggested that Ena/VASP proteins are involved in the formation and function of cellular junctions. Here, we establish the importance of Ena/VASP in endothelial junctions in vivo by analysis of Ena/VASP-deficient animals. In the absence of Ena/VASP, the vasculature exhibits patterning defects and lacks structural integrity, leading to edema, hemorrhaging, and late stage embryonic lethality. In endothelial cells, we find that Ena/VASP activity is required for normal F-actin content, actomyosin contractility, and proper response to shear stress. These findings demonstrate that Ena/VASP is critical for actin cytoskeleton remodeling events involved in the maintenance of functional endothelia.

C. Furman's present address is Pfizer Research Technology Center, Cambridge, MA 02139.

A.V. Kwiatkowski's present address is Dept. of Biological Sciences, Stanford University, Stanford, CA 94305.

Abbreviations used in this paper: E, embryonic day; Ena/VASP, Enabled/vasodilator-stimulated phosphoprotein; HUVEC, human umbilical vein endothelial cell; Mena, mammalian Ena; MLC, myosin light chain; PECAM, platelet/endothelial cell adhesion molecule; VE-cadherin, vascular endothelial–cadherin; ZO, zonula occludens.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents